150 related articles for article (PubMed ID: 20797415)
1. Microbial production of virus-like particle vaccine protein at gram-per-litre levels.
Liew MW; Rajendran A; Middelberg AP
J Biotechnol; 2010 Oct; 150(2):224-31. PubMed ID: 20797415
[TBL] [Abstract][Full Text] [Related]
2. A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines.
Middelberg AP; Rivera-Hernandez T; Wibowo N; Lua LH; Fan Y; Magor G; Chang C; Chuan YP; Good MF; Batzloff MR
Vaccine; 2011 Sep; 29(41):7154-62. PubMed ID: 21651936
[TBL] [Abstract][Full Text] [Related]
3. High-throughput process development of an alternative platform for the production of virus-like particles in Escherichia coli.
Ladd Effio C; Baumann P; Weigel C; Vormittag P; Middelberg A; Hubbuch J
J Biotechnol; 2016 Feb; 219():7-19. PubMed ID: 26707548
[TBL] [Abstract][Full Text] [Related]
4. Integrated molecular and bioprocess engineering for bacterially produced immunogenic modular virus-like particle vaccine displaying 18 kDa rotavirus antigen.
Tekewe A; Fan Y; Tan E; Middelberg AP; Lua LH
Biotechnol Bioeng; 2017 Feb; 114(2):397-406. PubMed ID: 27497268
[TBL] [Abstract][Full Text] [Related]
5. [High-cell density cultivation of recombinant Escherichia coli for production of TRAIL by using a 2-stage feeding strategy].
Zhang Y; Shen YL; Xia XX; Sun AY; Wei DZ; Zhou JS; Zhang GJ; Wang LH; Jiao BH
Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):408-13. PubMed ID: 15971615
[TBL] [Abstract][Full Text] [Related]
6. VP1 pseudocapsids, but not a glutathione-S-transferase VP1 fusion protein, prevent polyomavirus infection in a T-cell immune deficient experimental mouse model.
Vlastos A; Andreasson K; Tegerstedt K; Holländerová D; Heidari S; Forstová J; Ramqvist T; Dalianis T
J Med Virol; 2003 Jun; 70(2):293-300. PubMed ID: 12696121
[TBL] [Abstract][Full Text] [Related]
7. [Hepatitis E virus capsid protein production by high cell density culture of recombinant Escherichia coli].
Liu RS; He ZQ; Li SW; Yang KY; Xian YL; Pang SQ; Zhang J; Li YM; Xia NS
Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):450-5. PubMed ID: 15971623
[TBL] [Abstract][Full Text] [Related]
8. Production and biomedical applications of virus-like particles derived from polyomaviruses.
Teunissen EA; de Raad M; Mastrobattista E
J Control Release; 2013 Nov; 172(1):305-321. PubMed ID: 23999392
[TBL] [Abstract][Full Text] [Related]
9. Enhanced production of human mini-proinsulin in fed-batch cultures at high cell density of Escherichia coli BL21(DE3)[pET-3aT2M2].
Shin CS; Hong MS; Bae CS; Lee J
Biotechnol Prog; 1997; 13(3):249-57. PubMed ID: 9190075
[TBL] [Abstract][Full Text] [Related]
10. Encapsulation of DNA and non-viral protein changes the structure of murine polyomavirus virus-like particles.
Lipin DI; Chuan YP; Lua LH; Middelberg AP
Arch Virol; 2008; 153(11):2027-39. PubMed ID: 18979257
[TBL] [Abstract][Full Text] [Related]
11. Enterovirus 71 virus-like particle vaccine: improved production conditions for enhanced yield.
Chung CY; Chen CY; Lin SY; Chung YC; Chiu HY; Chi WK; Lin YL; Chiang BL; Chen WJ; Hu YC
Vaccine; 2010 Oct; 28(43):6951-7. PubMed ID: 20797455
[TBL] [Abstract][Full Text] [Related]
12. From shake flasks to bioreactors: survival of E. coli cells harboring pGST-hPTH through auto-induction by controlling initial content of yeast extract.
Jia L; Cheng H; Wang H; Luo H; Yan H
Appl Microbiol Biotechnol; 2011 May; 90(4):1419-28. PubMed ID: 21523618
[TBL] [Abstract][Full Text] [Related]
13. Generation of virus-like particles consisting of the major capsid protein VP1 of goose hemorrhagic polyomavirus and their application in serological tests.
Zielonka A; Gedvilaite A; Ulrich R; Lüschow D; Sasnauskas K; Müller H; Johne R
Virus Res; 2006 Sep; 120(1-2):128-37. PubMed ID: 16780983
[TBL] [Abstract][Full Text] [Related]
14. Affinity purification of viral protein having heterogeneous quaternary structure: modeling the impact of soluble aggregates on chromatographic performance.
Lipin DI; Raj A; Lua LH; Middelberg AP
J Chromatogr A; 2009 Jul; 1216(30):5696-708. PubMed ID: 19540501
[TBL] [Abstract][Full Text] [Related]
15. Size and position of truncations in the carboxy-terminal region of major capsid protein VP1 of hamster polyomavirus expressed in yeast determine its assembly capacity.
Gedvilaite A; Aleksaite E; Staniulis J; Ulrich R; Sasnauskas K
Arch Virol; 2006 Sep; 151(9):1811-25. PubMed ID: 16575481
[TBL] [Abstract][Full Text] [Related]
16. Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus.
Zhang YL; Guo YJ; Wang KY; Lu K; Li K; Zhu Y; Sun SH
Scand J Immunol; 2007 Apr; 65(4):320-8. PubMed ID: 17386022
[TBL] [Abstract][Full Text] [Related]
17. Production of recombinant bacteriocin divercin V41 by high cell density Escherichia coli batch and fed-batch cultures.
Yildirim S; Konrad D; Calvez S; Drider D; Prévost H; Lacroix C
Appl Microbiol Biotechnol; 2007 Dec; 77(3):525-31. PubMed ID: 17882416
[TBL] [Abstract][Full Text] [Related]
18. Enhanced production of recombinant streptokinase in Escherichia coli using fed-batch culture.
Goyal D; Sahni G; Sahoo DK
Bioresour Technol; 2009 Oct; 100(19):4468-74. PubMed ID: 19428239
[TBL] [Abstract][Full Text] [Related]
19. Oligonucleotide and plasmid DNA packaging into polyoma VP1 virus-like particles expressed in Escherichia coli.
Braun H; Boller K; Löwer J; Bertling WM; Zimmer A
Biotechnol Appl Biochem; 1999 Feb; 29 ( Pt 1)():31-43. PubMed ID: 9889083
[TBL] [Abstract][Full Text] [Related]
20. High yield expression in a recombinant E. coli of a codon optimized chicken anemia virus capsid protein VP1 useful for vaccine development.
Lee MS; Hseu YC; Lai GH; Chang WT; Chen HJ; Huang CH; Lee MS; Wang MY; Kao JY; You BJ; Lin W; Lien YY; Lin MK
Microb Cell Fact; 2011 Jul; 10():56. PubMed ID: 21781331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
